Stay updated with breaking news from Preclinical Data Published. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulatory progress for govorestat for the treatment of Classic Galactosemia, with potential NDA submission based on discussions with the FDA as well as EMA Marketing Authorization Application... -Today at 07:04 am- MarketScreener
– Preclinical Data Published in the Journal of Medicinal Chemistry Identifies Vidofludimus Calcium as a Potent Nurr1 Activator, Reinforcing Neuroprotective...
Issuer: Immunic, Inc. / Key word(s): Scientific publication Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis 17.05.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. I...
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
Preclinical Data Published in Nature Neuroscience Show Potential for ONWARD's ARCIM Therapy to Restore Movement in Hands and Arms after Spinal Cord Injury ONWARD Medical N.V. (Euronext: ONWD), the